Variable | Pancreatic duct stent group (n = 141) | Non-pancreatic duct stent group (n = 88) | P |
---|---|---|---|
AMY[U/L,M (IQR)] | |||
 On admission | 1123.70 (717.00–17912.00) | 865.75 (504.75–1316.85) | 0.011 |
 72 h | 145.70 (97.60–279.05) | 107.30 (66.80–168.10) | 0.001 |
 Difference | 869.00 (506.45–1483.40) | 680.70 (388.70–1163.00) | 0.085 |
WBC[× 109/L,M (IQR)] | |||
 On admission | 11.40 (8.66–15.35) | 10.97 (7.99–15.13) | 0.465 |
 72 h | 9.23 (6.09–11.93) | 7.95 (5.59–10.89) | 0.083 |
 Difference | 1.88 (-0.88–5.86) | 2.15 (-0.07–5.96) | 0.462 |
ALT[U/L,M (IQR)] | |||
 On admission | 243.80 (118.50–423.90) | 257.10 (150.65–426.50) | 0.416 |
 72 h | 97.00 (56.55–172.20) | 110.00 (70.90–179.15) | 0.220 |
 Difference | 114.40 (52.55–248.25) | 125.90 (51.55–252.40) | 0.712 |
TBIL[umol/L,M (IQR)] | |||
 On admission | 68.70 (41.55–114.30) | 86.10 (50.15–117.85) | 0.117 |
 72 h | 30.30 (18.00–46.20) | 29.80 (19.50–55.60) | 0.439 |
 Difference | 37.60 (14.85–69.15) | 41.50 (21.15–73.00) | 0.216 |
HCT[%,M (IQR)] | |||
 On admission | 43.60 (39.35–47.45) | 41.25 (37.83–44.10) | 0.001 |
 72 h | 38.90 (34.85–42.85) | 38.40 (35.70–40.85) | 0.422 |
 Difference | 4.40 (1.75–7.40) | 2.40 (0.80–5.20) | 0.001 |
LIP[IU/L,M (IQR)] | |||
 On admission | 8582.50 (4292.50–14294.50) | 5222.50 (709.50–9957.00) | 0.012 |
 72 h | 717.00 (413.00–1525.50) | 609.00 (296.25–1174.00) | 0.085 |
 Difference | 7322.00 (3561.00–13507.00) | 3011.00 (70.00–9036.00) | 0.006 |
CR[umol/L,M (IQR)] | |||
 On admission | 65.80 (55.95–80.40) | 68.00 (52.85–80.47) | 0.862 |
 72 h | 61.30 (50.60–73.35) | 59.50 (50.77–74.52) | 0.598 |
 Difference | 3.50 (− 1.85–12.70) | 5.15 (− 0.42–13.93) | 0.206 |